TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.230

+1.5%

Nov 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: robert miller who wrote (409)	6/7/2004 9:20:33 AM
From: Michael Bakunin	Read Replies (1) of 557

Where do you get the institutional data? Anyhow, as predicted, there's been a bunch of positive news flow, both by TGEN specifically and in the space generally. Full disclosure: while I considered it, I did not put on a buy-the-rumor trade here. No big TGEN pop for me. PR specifics include an expanded AAV license with NIH, complete RA suppression in animal models, and a puff piece reporting an ASGT presentation that "highlighted [AAV] for its potential utility." biz.yahoo.com biz.yahoo.com biz.yahoo.com I'd say tk's annual meeting report contained more useful information that the above three press releases. The RA release does make me wonder about the Amgen/Immunex licensing issue. Why did Amgen take so long on this? The merger was a while ago now. As for the stream of PR, I wonder if this means TGEN is planning another financing round if market conditions continue to improve. They don't have tons of cash.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next